Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 436 Issue 7050, 28 July 2005

Volume 436 Issue 7050

Subscribe

Editorial

  • The nuclear technology transfer deal agreed by the United States and India makes some sense on its own merits — but it leaves international non-proliferation efforts in disarray.

    Editorial

    Advertisement

  • The proposed European Research Council will be safest under the wing of the European Commission.

    Editorial

  • The US Food and Drug Administration badly needs some strong and stable leadership.

    Editorial
Top of page ⤴

Research Highlights

Top of page ⤴

News

Top of page ⤴

News in Brief

Top of page ⤴

News Feature

  • As spokesman for America's scientific élite, Ralph Cicerone will have to do some tough talking in Washington. Emma Marris asks him how he'll ensure that politicians will listen to the science.

    • Emma Marris
    News Feature

  • After centuries of playing second fiddle to the blood system, our lymphatic circulation is coming into its own as a key player in diseases ranging from cancer to asthma. Phyllida Brown reports.

    • Phyllida Brown
    News Feature
Top of page ⤴

Business

  • Still reeling from the loss of its blockbuster pill Vioxx, Merck is now in court to face its first lawsuit over the drug. Meredith Wadman reports.

    Business
Top of page ⤴

Correspondence

Top of page ⤴

Books & Arts

Top of page ⤴

Essay

  • An elegant orientation solution that is used by ants to get back to their nest eluded even Richard Feynman, suggesting that social insects could help to solve many of our engineering problems.

    • Francis Ratnieks
    Essay
Top of page ⤴

News & Views

  • The first detection of geoneutrinos from beneath our feet is a landmark result. It will allow better estimation of the abundances and distributions of radioactive elements in the Earth, and of the Earth's overall heat budget.

    • William F. McDonough
    News & Views

  • Traditional chemotherapy kills tumour cells directly; some newer drugs work instead by cutting the tumour's blood supply. An innovative approach combines these strategies sequentially to pack a double whammy.

    • David Mooney
    News & Views

  • The inorganic carbon carried in rivers of the Amazon basin seems to originate largely from the decomposition of young plant material — a finding that improves our understanding of the role of rivers in the carbon cycle.

    • Peter A. Raymond
    News & Views

  • Choosing whether to stick to a belief or to abandon it in the face of uncertainty is central to human behaviour. Modelling implicates brain chemicals called neuromodulators in adjudicating this essential decision.

    • Jonathan D. Cohen
    • Gary Aston-Jones
    News & Views

  • Two experiments that use nonlinear crystals to control the spatial distribution of photons in optical images bring the field of quantum imaging closer to maturity. Quantum information processing could ultimately benefit.

    • Claude Fabre
    News & Views

  • A genomic survey uses innovative genetics to make neurons susceptible to RNA-mediated gene inactivation. The results implicate many genes in communication at the synapse between neurons and muscle.

    • Cori Bargmann
    News & Views
Top of page ⤴

Brief Communication

Top of page ⤴

India

    • Apoorva Mandavilli

    Nature Outlook:

    India

  • Inder Verma celebrates the recent success of India's biotechnology industry, applauds the increased investment and looks to the future.

    • Inder Verma

    Nature Outlook:

    India

  • India's thriving biotechnology industry is threatened by a change in the law. Will the current high levels of investment be enough to secure its future? K. S. Jayaraman finds out.

    • K. S. Jayaraman

    Nature Outlook:

    India

  • One of the largest ever vaccine studies is under way in Kolkata. Paroma Basu uncovers the benefits, and difficulties, of inoculating 60,000 people against cholera and typhoid fever.

    • Paroma Basu

    Nature Outlook:

    India

  • Drug companies are converging on India to conduct low-cost clinical trials. But is it ready to become the outsourcing centre for the world? T. V. Padma investigates.

    • T. V. Padma

    Nature Outlook:

    India

  • Science and business are racing to tap the 3,000-year-old system of medicine for new drugs, says T. V. Padma.

    • T. V. Padma

    Nature Outlook:

    India

  • Mriganka Sur says that life sciences will prosper in India once research and teaching reconnect.

    • Mriganka Sur

    Nature Outlook:

    India

  • Reagents may be slow to arrive, but the freedom to explore his own research interests more than compensates. Satyajit Mayor is thriving in India.

    • Satyajit Mayor

    Nature Outlook:

    India

  • Researchers are suffering as a result of the conflicts between funding agencies. T. V. Padma uncovers plans to heal the rift.

    • T. V. Padma

    Nature Outlook:

    India

  • India's life-sciences institutes are rewriting the rule books for research. K. S. Jayaraman finds that they are focusing on higher standards and enterprise.

    • K. S. Jayaraman

    Nature Outlook:

    India

  • A staggering 5.1 million people are estimated to be HIV positive in India. Apoorva Mandavilli finds a country on the brink of a crisis.

    • Apoorva Mandavilli

    Nature Outlook:

    India
Top of page ⤴

Article

Top of page ⤴

Letter

Top of page ⤴

Prospects

  • Subcontinent is becoming more than an outsourcing outpost

    • Paul Smaglik
    Prospects
Top of page ⤴

Movers

Top of page ⤴

Career View

  • Open-source offers solutions for science software education

    • Greg Wilson
    Career View
Top of page ⤴

Graduate Journal

  • Graduate student evaluates pecking order

    • Karolina Tkaczuk
    Graduate Journal
Top of page ⤴

Futures

Top of page ⤴

Brief Communications Arising

Top of page ⤴
Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links